Clearing hidden malaria to help eliminate the disease in Rwanda
Part of Infections clinical trials.
This study tests a way to clear hidden malaria parasites in people who don't feel sick, to help stop the spread of malaria in Rwanda.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have malaria parasites in your blood but feel fine.
- You are between 18 and 65 years old.
- If you are not Rwandan, you must plan to stay in Rwanda for at least one month.
- You are not taking any malaria drugs for prevention or treatment.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to prevent malaria in children living in Busia District, Uganda. It combines malaria vaccines with preventive medicine to see if it offers better protection than current methods.
This study tests a new malaria vaccine in healthy adults. You will receive the vaccine and then be exposed to the malaria parasite in a controlled setting to check if the vaccine protects you.
This study tests a genetically modified malaria parasite that is intentionally given to healthy volunteers through a mosquito bite. The goal is to see if it is safe and to learn how the immune system responds, which could help develop a malaria vaccine.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
This trial tests a new malaria drug (MMV055), alone or with another drug (MMV371), to see if it is safe and how the body processes it. It is for healthy people who want to help find new malaria treatments.
Hear when a new Malaria Falciparum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.